Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL45484 | 0.84 | LMNA (0.38) | LMNAALDH1A1GAAKMT2ARECQL | |
| SCHEMBL515504 | 0.84 | LMNA (0.38) | LMNAALDH1A1GAAKMT2ARECQL | |
| SCHEMBL45483 | 0.84 | LMNA (0.38) | LMNAALDH1A1GAAKMT2ARECQL | |
| SCHEMBL10060147 | 0.82 | LMNA (0.40) | LMNAALDH1A1GAAKMT2ARECQL | |
| SCHEMBL13423390 | 0.79 | LMNA (0.43) | LMNAALDH1A1GAAKMT2ARECQL | |
| SCHEMBL7640624 | 0.74 | LMNA (0.36) | LMNAALDH1A1GAAKMT2ARECQL | |
| SCHEMBL7640620 | 0.74 | LMNA (0.36) | LMNAALDH1A1GAAKMT2ARECQL | |
| SCHEMBL12808261 | 0.71 | — | — | |
| SCHEMBL18623488 | 0.69 | ALDH1A1 (0.43) | LMNAALDH1A1GAAKMT2ARECQL | |
| SCHEMBL13168806 | 0.69 | ALDH1A1 (0.43) | LMNAALDH1A1GAAKMT2ARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8097603-B2 | Compositions for controlling parasites on animals | BAYER ANIMAL HEALTH GMBH (DE) | 2012-01-17 | — | — | US | disclosed |
| US-20100298136-A1 | ACTIVE INGREDIENT COMBINATIONS WITH INSECTICIDAL PROPERTIES | BAYER CROPSCIENCE AG (DE) | 2010-11-25 | — | — | US | disclosed |
| US-20100113268-A1 | SYNERGISTIC ACTIVE COMPOUND COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2010-05-06 | — | — | US | disclosed |
| EP-1893020-B1 | DERIVATIVES OF A 1-PHENYLTRIAZOLE AS ANTIPARASITIC AGENTS | BASF SE (DE) | 2010-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298136-A1 | ACTIVE INGREDIENT COMBINATIONS WITH INSECTICIDAL PROPERTIES | ACHE, DDT, BCHE | LMNA 3103/4885ALDH1A1 2122/4885GAA 929/4885 |
| US-20100113268-A1 | SYNERGISTIC ACTIVE COMPOUND COMBINATIONS | MASTL, NCLN, OXA1L | LMNA 4331/4885ALDH1A1 3717/4885GAA 895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.